Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells

Atherosclerosis
S KiharaY Matsuzawa

Abstract

The thiazolidinedione analogue troglitazone is an antidiabetic agent that improves insulin resistance in rodents and humans. Although coronary artery disease is common in patients with the insulin resistance syndrome, the effects of troglitazone on smooth muscle cells (SMC) have not been fully elucidated. We therefore examined the effects of troglitazone on cell growth and glucose uptake in human aortic SMC. Mitogen-activated protein (MAP) kinase activity and glucose transporter (Glut) 1 mRNA levels were also studied. In the absence of troglitazone, insulin (10(-7) M) caused a 2-fold increase of DNA synthesis in SMC and troglitazone suppressed the increase of DNA synthesis in a dose-dependent manner. This growth suppression was accompanied by inhibition of MAP kinase activity. On the other hand, troglitazone significantly increased Glut 1 mRNA and enhanced glucose uptake in SMC. These results suggest that troglitazone affects the insulin signaling pathways in SMC and suppresses growth while promoting glucose uptake. Our findings support the application of troglitazone as an inhibitor of SMC proliferation in patients with insulin resistance.

References

Mar 1, 1992·Diabetes Care·R A DeFronzoE Ferrannini
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L B Ray, T W Sturgill
Feb 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G K BandyopadhyayS Nandi
Jan 1, 1993·Progress in Lipid Research·S D Clarke, D B Jump
Nov 3, 1994·The New England Journal of Medicine·J J NolanJ Olefsky
Aug 1, 1994·Metabolism: Clinical and Experimental·I M el-KebbiR J Pollet
Oct 15, 1996·The Journal of Clinical Investigation·R E LawW A Hsueh

❮ Previous
Next ❯

Citations

Apr 23, 2002·Pharmacogenomics·Carsten OttoBurkhard Göke
Dec 27, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zoran HajdukovićSlavica Raden
May 10, 2011·International Journal of Biological Macromolecules·Wan-Ling LinYong-Gang Wang
Jul 20, 2007·Progress in Lipid Research·Nikolaus Marx, Daniel Walcher
May 2, 2006·Prostaglandins & Other Lipid Mediators·Philip FunovicsAlicja Jozkowicz
Feb 20, 2007·The American Journal of Cardiology·Gabriel I Uwaifo, Robert E Ratner
Sep 4, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Kevin B AtkinsFrank C Brosius
Apr 25, 2000·The Journal of Biological Chemistry·K KishidaY Matsuzawa
Dec 31, 2002·Physiological Reviews·Giovanni E MannLuis Sobrevia
May 26, 2015·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Jacob D Peuler, Laura E Phelps
Sep 27, 2003·Melanoma Research·Wojciech PlachaPiotr Laidler
Nov 17, 2009·Journal of Proteome Research·Renato MillioniPaolo Tessari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.